Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00228046 · ClinicalTrials.gov registry record · Phase 4
Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
A Phase 4 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00228046: Completed Phase 4 study, sponsored by Stony Brook University.
NCT00228046 is a Phase 4 study that has completed, run by Stony Brook University. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00228046, a Phase 4 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit hyperactivity disorder (ADHD).
Interventions
- DRUG Methylphenidate
- DRUG Divalproex Sodium
- DRUG Dextroamphetamine
- BEHAVIORAL Family Counseling
- DRUG Mixed Amphetamine Salts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-01 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
What the finished NCT00228046 record still lists
NCT00228046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 5 interventions - of which Methylphenidate is the first listed.
NCT00228046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00228046 about?
NCT00228046 is a clinical study titled "Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder". This study will assess whether adding a mood stabilizer, divalproex sodium, to stimulant treatment is more effective than stimulant treatment alone in reducing aggressive behavior among children with attention deficit hyperactivity disorder (ADHD).
What is the current status of trial NCT00228046?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-01. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00228046?
The interventions under investigation include: Methylphenidate (DRUG), Divalproex Sodium (DRUG), Dextroamphetamine (DRUG), Family Counseling (BEHAVIORAL), Mixed Amphetamine Salts (DRUG).
Who is sponsoring clinical trial NCT00228046?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00228046's enrollment target sits among peer trials
40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia